Your browser doesn't support javascript.
loading
Prognostic role of preoperative carcinoembryonic antigen level in part-solid lung adenocarcinoma.
Yamanashi, Keiji; Hamaji, Masatsugu; Murakami, Kotaro; Shimada, Yoshihisa; Kayawake, Hidenao; Yutaka, Yojiro; Kawaguchi, Yohei; Kudo, Yujin; Ikeda, Norihiko; Date, Hiroshi.
Afiliação
  • Yamanashi K; Department of Thoracic Surgery, Graduate School of Medicine, 12918Kyoto University, Japan.
  • Hamaji M; Department of Thoracic Surgery, Graduate School of Medicine, 12918Kyoto University, Japan.
  • Murakami K; 34797Department of Surgery, 13112Tokyo Medical University, Japan.
  • Shimada Y; 34797Department of Surgery, 13112Tokyo Medical University, Japan.
  • Kayawake H; Department of Thoracic Surgery, Graduate School of Medicine, 12918Kyoto University, Japan.
  • Yutaka Y; Department of Thoracic Surgery, Graduate School of Medicine, 12918Kyoto University, Japan.
  • Kawaguchi Y; 34797Department of Surgery, 13112Tokyo Medical University, Japan.
  • Kudo Y; 34797Department of Surgery, 13112Tokyo Medical University, Japan.
  • Ikeda N; 34797Department of Surgery, 13112Tokyo Medical University, Japan.
  • Date H; Department of Thoracic Surgery, Graduate School of Medicine, 12918Kyoto University, Japan.
Asian Cardiovasc Thorac Ann ; 30(4): 457-467, 2022 May.
Article em En | MEDLINE | ID: mdl-35040362
BACKGROUND: Part-solid lung adenocarcinoma appears as a heterogeneous subgroup, and its surgical management is controversial. This study aimed to elucidate whether preoperative carcinoembryonic antigen, a time-honored tumor marker, can be used as a prognostic factor that contributes to its management. METHODS: We retrospectively reviewed consecutive patients with clinical-T1a-cN0M0 part-solid adenocarcinoma who underwent surgical resection between January 2011 and December 2015 at two institutions. RESULTS: Overall, 288 patients were identified. The median age was 69 years with 176 patients (61%) being female. The median follow-up time was 5.6 years. Lymph node metastases were found in 6 (15%) of 41 patients with elevated carcinoembryonic antigen levels, while 10 (4.0%) of 247 patients had normal carcinoembryonic antigen levels (P = 0.016). The 5-year overall survival rates in patients with normal and elevated carcinoembryonic antigen levels were 96.9% and 87.2%, respectively (P = 0.006), and the 5-year relapse-free survival rates were 91.8% and 62.8%, respectively (P < 0.001). The multivariable analysis revealed that preoperative carcinoembryonic antigen level was a significant prognostic factor for relapse-free survival (hazard ratio [HR] = 2.92, 95% confidence interval [CI] = 1.63-5.25, P < 0.001). Among the patients with elevated carcinoembryonic antigen levels, the 5-year overall survival rates in those undergoing lobar resection and segmentectomy were 87.0% and 88.9%, respectively (P = 0.59), and the 5-year relapse-free survival rates were 61.7% and 66.7%, respectively (P = 0.84). CONCLUSIONS: Our data suggest that preoperative carcinoembryonic antigen level appears to be an important predictor of postoperative survival outcomes in early-stage part-solid adenocarcinoma. Further studies are required to optimize management of patients with elevated preoperative carcinoembryonic antigen levels, although segmentectomy appeared acceptable in those patients.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Adenocarcinoma / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Asian Cardiovasc Thorac Ann Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Adenocarcinoma / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Asian Cardiovasc Thorac Ann Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão